What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Alzheimer's disease
- Disease
Alzheimer's disease, Internal medicine, Pathology, Apolipoprotein E and Dementia are her primary areas of study.
The Alzheimer's disease study combines topics in areas such as Biomarker, Cerebrospinal fluid and Immunology.
Her Biomarker study combines topics from a wide range of disciplines, such as Amyloid beta and Neuroscience.
Her biological study deals with issues like Oncology, which deal with fields such as Csf biomarkers.
Her Apolipoprotein E research is multidisciplinary, relying on both Allele, Transgene, Brain mapping and Degenerative disease.
Anne M. Fagan combines subjects such as Occipital lobe and PSEN1 with her study of Dementia.
Her most cited work include:
- Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (4114 citations)
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease (2062 citations)
- Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. (1016 citations)
What are the main themes of her work throughout her whole career to date?
Her scientific interests lie mostly in Alzheimer's disease, Internal medicine, Disease, Cerebrospinal fluid and Pathology.
Her work deals with themes such as Biomarker, Cognition and Dementia, Cognitive decline, which intersect with Alzheimer's disease.
Her Biomarker research is multidisciplinary, incorporating perspectives in Hippocampus, Asymptomatic and Neuroimaging.
Her Internal medicine research is multidisciplinary, incorporating elements of Endocrinology and Oncology.
Her Disease study incorporates themes from Genetics, Clinical trial, Bioinformatics, Psychiatry and Neuroscience.
Her Cerebrospinal fluid research includes themes of Positron emission tomography, Single-nucleotide polymorphism, Immunology and Endophenotype.
She most often published in these fields:
- Alzheimer's disease (40.94%)
- Internal medicine (38.82%)
- Disease (32.00%)
What were the highlights of her more recent work (between 2017-2021)?
- Internal medicine (38.82%)
- Alzheimer's disease (40.94%)
- Biomarker (21.18%)
In recent papers she was focusing on the following fields of study:
Anne M. Fagan focuses on Internal medicine, Alzheimer's disease, Biomarker, Disease and Oncology.
In her work, Vascular dementia is strongly intertwined with Endocrinology, which is a subfield of Internal medicine.
Her Alzheimer's disease research also works with subjects such as
- Cognitive decline which intersects with area such as Effects of sleep deprivation on cognitive performance,
- Physical medicine and rehabilitation that intertwine with fields like Spatial memory.
Her research in Biomarker intersects with topics in Cerebrospinal fluid, Neurodegeneration, Neuroimaging, Dementia and Hippocampus.
Her Cerebrospinal fluid research is under the purview of Pathology.
Anne M. Fagan has researched Disease in several fields, including Neuroscience, Immunology, Atrophy and Bioinformatics.
Between 2017 and 2021, her most popular works were:
- Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. (337 citations)
- APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. (158 citations)
- Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study (143 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Alzheimer's disease
- Disease
Her primary scientific interests are in Alzheimer's disease, Biomarker, Cerebrospinal fluid, Internal medicine and Disease.
Anne M. Fagan interconnects Clinical trial and Brain mapping in the investigation of issues within Alzheimer's disease.
Her biological study spans a wide range of topics, including Csf biomarkers, Pittsburgh compound B, Asymptomatic, Cognitive decline and Apolipoprotein E.
Cerebrospinal fluid is a subfield of Pathology that Anne M. Fagan investigates.
Her research integrates issues of Gastroenterology, Endocrinology and Oncology in her study of Internal medicine.
Her studies in Dementia integrate themes in fields like Amyloid β and Gene mutation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
